References
- 1. Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: A review. JAMA. 2020 May 19;323(19):1945-60. DOI: 10.1001/jama.2020.400610.1001/jama.2020.400632427307
- 2. Lee EB, Wu KK, Lee MP, Bhutani T, Wu JJ. Psoriasis risk factors and triggers. Cutis. 2018 Nov;(5S):18-20.
- 3. Takemoto A, Cho O, Morohoshi Y, Sugita T, Muto M. Molecular characterization of the skin fungal microbiome in patients with psoriasis. J Dermatol. 2015 Feb;42(2):166-70. DOI: 10.1111/1346-8138.1273910.1111/1346-8138.1273925510344
- 4. Lewis DJ, Chan WH, Hinojosa T, Hsu S, Feldman SR. Mechanisms of microbial pathogenesis and the role of the skin microbiome in psoriasis: A review. Clin Dermatol. 2019 Mar-Apr;37(2):160-6. DOI: 10.1016/j. clindermatol.2019.01.01110.1016/j.clindermatol.2019.01.011
- 5. Zomorodian K, Mirhendi H, Tarazooie B, Zeraati H, Hallaji Z, Balighi K. Distribution of Malassezia species in patients with psoriasis and healty individuals in Tehran, Iran. J Cutan Pathol. 2008 Nov; 35811:1027-31. DOI: 10.1111/j.1600-0560.2007.00968.x10.1111/j.1600-0560.2007.00968.x18616765
- 6. Benhadou F, Mintoff D, Schnebert B, Thio HB. Psoriasis and microbiota: A systematic review. Diseases. 2018 Jun;6(2):47. DOI: 10.3390/diseases602004710.3390/diseases6020047602339229865237
- 7. Lober CW, Belew PW, Rosenberg EW, Bale G. Patch tests with killed sonicated microflora in patients with psoriasis. Arch Dermatol. 1982 May;118(5):322-5. DOI: 10.1001/archderm.118.5.32210.1001/archderm.118.5.322
- 8. Narang T, Dogra S, Kaur I, Kanwar AJ. Malassezia and psoriasis: Koebner’s phenomenon or direct causation? J Eur Acad Dermatol Venereol. 2007 Sep;21(8):1111-2. DOI: 10.1111/j.1468-3083.2006.02097.x10.1111/j.1468-3083.2006.02097.x17714138
- 9. Bunse T, Mahrle G. Soluble Pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients. Acta Derm Venereol. 1996 Jan;76(1):10-2.10.2340/00015555761012
- 10. Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012 Jan;25(1):106-41. DOI: 10.1128/CMR.00021-1110.1128/CMR.00021-11325596222232373
- 11. Ashbee HR, Evans EGV. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev. 2002 Jan;15:21-57. DOI: 10.1128/CMR.15.1.21-57.200210.1128/CMR.15.1.21-57.200211805811781265
- 12. Ertam I, Aytimur D. Malassezia spp. ve Dermatoloji’deki Yeri. Turkderm. 2006;40(1):7-10.
- 13. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL. Jr. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004 Nov;51(5):785-98. DOI: 10.1016/j.jaad.2003.12.03410.1016/j.jaad.2003.12.03415523360
- 14. Kantarcioglu AS, Yucel A. Malassezia türleri: taksonomi, mikoloji, immünoloji, patogenez, vücuttaki dağılımı ve ilişkili infeksiyonlar, laboratuvar tanımı, antifungallere duyarlılığı. Cerrahpaşa J Med. 2005;36:134-54.
- 15. Rodoplu G, Saracli MA, Gumral R, Yildiran ST. Distribution of Malassezia species in patients with pityriasis versicolor in Turkey. Journal de Mycologie Medicale. 2014 June;24(2):117-23. DOI: 10.1016/j.mycmed.2014.02.00110.1016/j.mycmed.2014.02.00124746716
- 16. Midgley G, Gueho E, Guillot J. Disease caused by Malassezia species. Topley and Wilson’s Microbiology and microbial infections. 9th edition. Edited by: Ajello L, Hay RJ. London: Arnold 1998;4:201-11.
- 17. Bayraktar S, Duran N, Duran GG, Eryilmaz N, Aslan H, Onlen C, et al. Identification of medically important Candida species by polymerase chain reaction-restriction fragment length polymorphism analysis of the rDNA ITS1 and ITS2 regions. Indian J Med Microbiol. 2017 Oct-Dec;35(4):535-42. DOI: 10.4103/ijmm. IJMM_17_10210.4103/ijmm.IJMM_17_102
- 18. Thomas DS, Ingham E, Bojar RA, Holland KT. In vitro modulation of human keratinocyte pro- and anti-inflammatory cytokine production by the capsule of Malassezia species. FEMS Immunol Med Micro-biol. 2008 Nov;54(2):203-14. DOI: 10.1111/j.1574-695X.2008.00468.x10.1111/j.1574-695X.2008.00468.x18752620
- 19. Kesavan S, Holland KT, Ingham E. The effects of lipid extraction on the immunomodulatory activity of Malassezia species in vitro. Med Mycol. 2000 Jun;38(3):239-47. DOI: 10.1080/mmy.38.3.239.24710.1080/mmy.38.3.239.24710892993
- 20. Belew PW, Rosenberg EW, Jennings BR. Activation of the alternative pathway of complement by Malassezia ovalis (Pityrosporum ovale). Mycopathologia. 1980;70(3):187-91. DOI: 10.1007/BF0044303010.1007/BF004430306900183
- 21. Squiquera L, Galimberti R, Morelli L, Plotkin L, Milicich R, Kowalckzuk A, et al. Antibodies to proteins from Pityrosporum ovale in the sera from patients with psoriasis. Clin Exp Dermatol. 1994 Jul;19(4):289-93. DOI: 10.1111/j.1365-2230.1994.tb01197.x10.1111/j.1365-2230.1994.tb01197.x7955467
- 22. Aydogan K, Tore O, Akcaglar S, Oral B, Ener B, Tunalı S, et al. Effects of Malassezia yeasts on serum Th1 and Th2 cytokines in patients with guttate psoriasis. Int J Dermatol. 2013 Jan;52(1):46-52. DOI: 10.1111/j.1365-4632.2011.05280.x10.1111/j.1365-4632.2011.05280.x22512309
- 23. Baroni A, Paolett I, Ruocc E, Agozzin M, Tufan MA, Donnarumma G. Possible role of Malassezia furfur in psoriasis: modulation of TGF- β1, integrin, and HSP70 expression in human keratinocytes and in the skin of psoriasis-affected patients. J Cutan Pathol. 2004 Jan;31(1):35-42. DOI: 10.1046/j.0303-6987.2004.0135.x10.1046/j.0303-6987.2004.0135.x14675283
- 24. Baroni A, Orlando M, Donnarumma G, Farro P, Iovene MR, Tufano MA, et al. Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur. Arch Dermatol Res. 2006 Jan;297(7):280-8. DOI: 10.1007/s00403-005-0594-410.1007/s00403-005-0594-416283346
- 25. Plotkin LI, Mathov I, Squiquera L, Leoni J. Arachidonic acid released from epithelial cells by Malassezia furfur phospholipase A2: a potential pathophysio-logic mechanism. Mycologia. 1998;90:163-9. DOI: 10.1080/00275514.1998.1202689510.1080/00275514.1998.12026895
- 26. Brunke S, Hube B. MfLIP1, a gene encoding an extra-cellular lipase of the lipid-dependent fungus Malassezia furfur. Microbiology. 2006 Feb;152:547-54. DOI: 10.1099/mic.0.28501-010.1099/mic.0.28501-016436442
- 27. Oh BH, Song YC, Lee YW, Choe YB, Ahn KJ. Comparison of Nested PCR and RFLP for Identification and Classification of Malassezia Yeasts from Healthy Human Skin. Ann Dermatol. 2009 Nov;21(4):352-7. DOI: 10.5021/ad.2009.21.4.35210.5021/ad.2009.21.4.352286126320523823
- 28. Prohic A. Identification of Malassezia species isolated from scalp skin of patients with psoriasis and healty subjects. Acta Dermatovenerol Croat. 2003;11(1):10-6.
- 29. Takahata Y, Sugita T, Hiruma M, Muto M. Quantitative analysis of Malassezia in the scale of patients with psoriasis using a real-time polymerase chain reaction assay. Br J Dermatol. 2007 Oct;157(4):670-3. DOI: 10.1111/j.1365-2133.2007.08090.x10.1111/j.1365-2133.2007.08090.x17634085
- 30. Paulino L, Tseng C, Blaser MJ. Analysis of Malassezia microbiota in healthy superficial human skin and psoriatic lesions by multiplex real-time PCR. FEMS Yeast Res. 2008;8:460-71. DOI: 10.1111/j.1567-1364.2008.00359.x10.1111/j.1567-1364.2008.00359.x18294199
- 31. Gomez-Moyano E, Crespo-Erchiga V, Martínez-Pilar L, Godoy Diaz D, Martínez- Garcia S, Lova Navarro M, et al. Do Malassezia species play a role in exacerbation of scalp psoriasis? J Mycol Med. 2014 Jun;24(2):87-92. DOI: 10.1016/j.mycmed.2013.10.00710.1016/j.mycmed.2013.10.00724411177
- 32. Tarazooie B, Kordbacheh P, Zaini F, Zomorodian K, Saadat F, Zeraati H, et al. Study of the distribution of Malassezia species in patients with pityriasis versicolor and healty individuals in Tehran, Iran. BMC Dermatol. 2004 May;4:5. DOI: 10.1186/1471-5945-4-510.1186/1471-5945-4-542173215119958
- 33. Gupta AK, Kohli Y, Summerball RC, Faergemann J. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol. 2001 Jun;39(3):243-51. DOI: 10.1080/71403102510.1080/714031025
- 34. Jagielski T, Rup E, Ziółkowska A, Roeske K, Macura AB, Bielecki J. Distribution of Malassezia species on the skin of patients with atopic dermatitis, psoriasis, and healthy volunteers assessed by conventional and molecular identification methods. BMC Dermatol. 2014 Mar;14:3. DOI: 10.1186/1471-5945-14-310.1186/1471-5945-14-3397558624602368
- 35. Tett A, Pasolli E, Farina S, Truong DT, Ascinar F, Zolfo M, et al. Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis. NPJ Biofilms Microbiomes. 2017 Jun;3:14. DOI: 10.1038/s41522-017-0022-510.1038/s41522-017-0022-5548141828649415
- 36. Amaya M, Tajima M, Okubo Y, Sugita T, Nishikawa A, Tsuboi R. Molecular analysis of Malassezia micro-flora in the lesional skin of psoriasis patients. J Dermatol. 2007 Sep;34(9):619-24. DOI: 10.1111/j.1346-8138.2007.00343.x10.1111/j.1346-8138.2007.00343.x17727364
- 37. Stehlikova Z, Kostovcik M, Kostovcikova K, Kverka M, Juzlova K, Rob F, et al. Dysbiosis of Skin Micro-biota in Psoriatic Patients: Co-occurrence of Fungal and Bacterial Communities. Front Microbiol. 2019 Mar;10:438. DOI: 10.3389/fmicb.2019.0043810.3389/fmicb.2019.00438643711030949136
- 38. Rudramurthy SM, Honnavar P, Chakrabarti A, Dogra S, Singh P, Handa S. Association of Malassezia species with psoriatic lesions. Mycoses. 2014 Aug;57(8):483-8. DOI: 10.1111/myc.1218610.1111/myc.1218624655111
- 39. Prohic A, Jovovic Sadikovic T, Krupalija-Fazlic M, Kuskunovic-Vlahovljak S. Malassezia species in healthy skin and in dermatological conditions. Int J Dermatol. 2016 May;55(5):494-504. DOI: 10.1111/ijd.1311610.1111/ijd.1311626710919